# Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia

> **NCT01737697** · PHASE3 · COMPLETED · sponsor: **ZS Pharma, Inc.** · enrollment: 754 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** Zirconium silicate (acute phase)
- **DRUG:** Zirconium silicate (subacute phase)
- **DRUG:** Placebo (acute phase)
- **DRUG:** Placebo ( subacute phase)

## Key facts

- **NCT ID:** NCT01737697
- **Lead sponsor:** ZS Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-30
- **Primary completion:** 2013-10-31
- **Final completion:** 2013-11-30
- **Target enrollment:** 754 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737697, "Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01737697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*